AURELUXA JOURNAL · THE SPF EDIT
Explore L-Ergothioneine, the research behind it, and where MITO-SHIELD fits in a daily sunscreen routine.
READ THE ARTICLEL-Ergothioneine research
Researchers identified OCTN1 as a transporter for L-Ergothioneine. Cells expressing it can take up and retain the compound, making transport an important part of its biology.
Transporter study · 2005
A study in epidermal keratinocytes found that cells could accumulate L-Ergothioneine. In the experimental UV conditions, this was associated with reduced oxidative damage.
Laboratory evidence · not a serum trial
Researchers studied L-Ergothioneine in UVA-exposed keratinocyte cells and reported changes in antioxidant signalling, oxidative stress and mitochondrial function. The work used a controlled laboratory model.
Ingredient study · controlled conditions
A study in human skin fibroblast cells examined L-Ergothioneine, antioxidant signalling and markers involved in collagen breakdown after UVA exposure. It did not test Mito-Shield or establish visible results in people.
Cell study · not a human clinical trial
Laboratory findings help us understand ingredients. They do not show that a finished serum will reproduce those results on human skin.
SOURCE LIBRARY
Explore four primary studies on L-Ergothioneine transport and antioxidant activity in laboratory models.
